Logo Image
|Articles|July 2, 2003

Pharmaceutical Technology

  • Pharmaceutical Technology-07-02-2003
  • Volume 27
  • Issue 7

Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance

Pharmaceutical companies must take a holistic look at their systems and supporting processes to implement FDA's risk-based approach into their 21 CFR Part 11 complaince strategies.
External Link - article-62502.pdf

Articles in this issue

almost 23 years ago

July 2003

almost 23 years ago

Gastrorentention: A Means to Address Regional Variability in Intestinal Drug Absorption

almost 23 years ago

The Push for Generics Challenges Manufacturers

almost 23 years ago

Emerging Research Opportunities in Oral Inhalation Technology

almost 23 years ago

Preventing Metal Contamination

almost 23 years ago

Capacity Worries Fade for Biomanufacturing